Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival

BACKGROUND. From 1988 to 1999, the Radiation Therapy Oncology Group (RTOG) conducted four prospective studies (8802, 8903, 9506, 9706) of patients with clinical stage T2–4a muscle-invasive bladder cancer. Treatment was selective bladder preservation using transurethral surgery (TURBT) plus cisplatin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lautenschlaeger, Tim, George, Asha, Klimowicz, Alexander C., Efstathiou, Jason A., Wu, Chin-Lee, Sandler, Howard, Shipley, William U., Tester, William J., Hagan, Michael P., Magliocco, Anthony M., Chakravarti, Arnab
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063394/
https://ncbi.nlm.nih.gov/pubmed/23728940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0461
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados